Understanding the ABG Results
First, let's interpret the arterial blood gas (ABG) values. The patient has a pH of
7.28, which is below the normal range of 7.35-7.45, indicating
acidosis. The PaCO₂ is
55 mmHg (normal 35-45 mmHg), which is elevated. An elevated PaCO₂ points to a
respiratory acidosis. The HCO₃⁻ is
26 mEq/L, which is within the normal range (22-26 mEq/L). This lack of metabolic compensation suggests the respiratory acidosis is acute in nature. This clinical picture is consistent with an acute exacerbation of chronic obstructive pulmonary disease (COPD) leading to hypercapnic acute respiratory failure (ARF)
[1].
Analyzing the Intervention Options
The goal of treatment is to improve ventilation and gas exchange while avoiding harm. Let's evaluate the options based on the underlying pathophysiology.
Option 1: Encourage deep breathing exercises and coughing techniques.
While these techniques are beneficial for airway clearance and preventing atelectasis in stable patients, they are insufficient as a primary intervention for a patient in acute respiratory failure with a pH of 7.28. The patient's primary problem is hypoventilation leading to CO₂ retention, which requires immediate ventilatory support, not just coaching.
Option 2: Position the patient in high Fowler's position and administer low-flow oxygen.
This is the most appropriate initial nursing action. High Fowler's position optimizes lung expansion by reducing pressure from the abdominal organs on the diaphragm. The critical component here is the administration of
low-flow oxygen. In COPD patients with chronic CO₂ retention, the respiratory drive can shift from a normal response to high CO₂ levels to a reliance on
hypoxic drive. Administering high concentrations of oxygen can suppress this drive, leading to further hypoventilation and worsening hypercapnia. The goal is to correct hypoxemia (PaO₂ of 70 mmHg is low) without eliminating the hypoxic drive, typically targeting an SpO₂ of 88-92%. This strategy supports the patient while preparing for or initiating physician-ordered non-invasive ventilation (NIV), which is the first-line ventilatory strategy for this condition
[1].
Option 3: Prepare for immediate intubation and mechanical ventilation.
This is premature as a first-line intervention. According to the provided evidence, non-invasive ventilation (NIV) is the current first-line ventilatory strategy for hypercapnic ARF in COPD exacerbation
[1]. Intubation is reserved for patients who fail NIV, have contraindications to NIV, or present with severe instability such as respiratory arrest. Jumping directly to an invasive procedure bypasses the standard, less invasive standard of care.
Option 4: Administer sodium bicarbonate as ordered by the physician.
This is contraindicated in respiratory acidosis. The problem is not a lack of bicarbonate (HCO₃⁻ is normal at 26 mEq/L) but an excess of CO₂. Administering sodium bicarbonate would provide a temporary buffering effect, but it generates more CO₂ as a byproduct, paradoxically worsening the underlying respiratory acidosis. The definitive treatment is to improve ventilation and blow off the excess CO₂.
Pathophysiology and Clinical Rationale
In an acute COPD exacerbation, worsening airflow limitation and increased dead space ventilation lead to a rapid rise in PaCO₂, overwhelming the kidneys' ability to compensate by retaining bicarbonate over several days. The resulting acute respiratory acidosis (low pH, high PaCO₂, normal HCO₃⁻) depresses the central nervous system and can progress to life-threatening complications. The immediate nursing priority is to support oxygenation and ventilation safely. High Fowler's position and carefully titrated low-flow oxygen address the hypoxemia while mitigating the risk of abolishing the hypoxic drive, a key safety consideration in this population. This intervention serves as a bridge to the definitive first-line therapy, which is NIV, as highlighted in the review of hypercapnic ARF management
[1].
References (research sources)
- [1]
Management of hypercapnic acute respiratory failure with high-flow nasal cannula therapy: A narrative review.Research articleGirault C, Artaud-Macari E, Declercq PL, Frat JP, Ricard JD, Thille AW, Béduneau G. (2026) · DOI: 10.1016/j.aicoj.2026.100053